ARCHIVES

The Selling Begins: CT Offered Beyond High-Risk Group

This article is from The Cancer Letter archive.

Vol. 36 No. 43 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP For the Month of April

April 27, 2012

In Brief: Cancer Center Scientist Set For Space Launch; NIH French Anderson Negotiating With USC

June 5, 1992

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

April 1, 1994

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007